Cyteir Therapeutics, Inc. (CYT) Financials

CYT Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 131.0 million 6.0 million
2023-06-30 134.4 million 6.6 million
2023-03-31 139.0 million 4.0 million
2022-12-31 153.2 million 6.9 million

CYT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.6 million 599000
2023-06-30 -4.1 million 776000
2023-03-31 -10.2 million 1.0 million
2022-12-31 -7.2 million 869000

CYT Net Income

No data available :(

CYT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 129.2 million - 16000
2023-06-30 133.6 million - 57000
2023-03-31 137.2 million - 98000
2022-12-31 147.1 million - 889000

CYT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 36.0 million
2023-06-30 35.7 million
2023-03-31 35.6 million
2022-12-31 35.4 million

CYT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 2.7 million 2.5 million -
2023-06-30 - 5.4 million 4.2 million -
2023-03-31 - 9.3 million 4.1 million -
2022-12-31 302000 7.5 million 2.6 million -

CYT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 100000
2023-06-30 - 100000
2023-03-31 - 308000
2022-12-31 - 326000

CYT

Price: $3.02

52 week price:
1.42
3.19

Payout Ratio Range:
1.44%
28.74%

Earnings Per Share: -0.93 USD

P/E Ratio: -3.38

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 92100

Market Capitalization: 108.7 million

Average Dividend Frequency: 4

Links: